Published in J Neurocytol on January 01, 1996
Campylobacter species and Guillain-Barré syndrome. Clin Microbiol Rev (1998) 4.39
Molecular composition of the node of Ranvier: identification of ankyrin-binding cell adhesion molecules neurofascin (mucin+/third FNIII domain-) and NrCAM at nodal axon segments. J Cell Biol (1996) 2.52
An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction. J Cell Biol (2000) 2.24
Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A (2004) 2.16
Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies. Exp Neurol (2011) 1.51
Intravenous IgG in Guillain-Barré syndrome. BMJ (1996) 1.38
Morphometric and ultrastructural changes with ageing in mouse peripheral nerve. J Anat (1999) 1.31
Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review. Glycobiology (2009) 1.19
Guillain-Barré syndrome. Postgrad Med J (2000) 1.07
Guillain-Barré syndrome and variants. Neurol Clin (2013) 1.06
Node of Ranvier disruption as a cause of neurological diseases. ASN Neuro (2013) 1.01
Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases. Front Cell Neurosci (2013) 0.94
Electron tomographic analysis of cytoskeletal cross-bridges in the paranodal region of the node of Ranvier in peripheral nerves. J Struct Biol (2007) 0.92
Two unusual variants of Guillain-Barre syndrome. BMJ Case Rep (2012) 0.92
Guillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey. Proc Jpn Acad Ser B Phys Biol Sci (2012) 0.90
Guillain-barré syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder. J Biomed Biotechnol (2010) 0.90
Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand? J Neurol (2009) 0.90
Anti-ganglioside antibodies alter presynaptic release and calcium influx. Neurobiol Dis (2007) 0.89
Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (1996) 0.86
Anti-Ganglioside Antibodies Induce Nodal and Axonal Injury via Fcγ Receptor-Mediated Inflammation. J Neurosci (2015) 0.82
Treatment guidelines for Guillain-Barré Syndrome. Ann Indian Acad Neurol (2011) 0.82
Neuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies? Glia (2015) 0.80
An update on pathobiologic roles of anti-glycan antibodies in Guillain-Barré syndrome. F1000 Biol Rep (2010) 0.80
Progress in inflammatory neuropathy -the legacy of Dr Jack Griffin. Nat Rev Neurol (2015) 0.79
An electrophysiological classification associated with Guillain-Barré syndrome outcomes. J Neurol (2014) 0.76
Identification of gene networks and pathways associated with Guillain-Barré syndrome. PLoS One (2012) 0.76
Guillain-Barré syndrome: a century of progress. Nat Rev Neurol (2016) 0.76
Acute Motor Axonal Neuropathy (Aman) With Motor Conduction Blocks In Childhood; Case Report. Iran J Child Neurol (2016) 0.75
C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy. Acta Neuropathol Commun (2016) 0.75
Are anti-ganglioside antibodies associated with proventricular dilatation disease in birds? PeerJ (2017) 0.75
Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice. Microbiome (2017) 0.75
Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification. J Neurol (2016) 0.75
Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol (1971) 20.35
Adhesive force of a single gecko foot-hair. Nature (2000) 10.56
Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol (1990) 8.54
Esterases in human leukocytes. J Histochem Cytochem (1973) 7.37
Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2011) 7.09
Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature (2001) 5.07
Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res (2001) 4.87
The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) (1969) 4.72
Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group. J Natl Cancer Inst (1997) 3.61
The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology (2003) 3.60
Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol (1998) 3.39
Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 3.23
EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol (2005) 3.17
Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival. Leukemia (2008) 3.04
Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet (1991) 2.87
Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2003) 2.76
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol (1990) 2.66
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol (1981) 2.53
Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol (1998) 2.47
Myeloma with involvement of the serous cavities. Cytologic and immunochemical diagnosis and literature review. Acta Cytol (1990) 2.36
Multifocal motor neuropathy: response to human immune globulin. Ann Neurol (1993) 2.32
Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology (2007) 2.32
Diffusion- and perfusion-weighted brain magnetic resonance imaging in patients with neurologic complications after cardiac surgery. Arch Neurol (2001) 2.30
Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain (1995) 2.29
Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol (1993) 2.23
Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology (2001) 2.15
Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology (1997) 2.15
The role of Schwann cells in the formation of "onion bulbs" found in chronic neuropathies. J Neuropathol Exp Neurol (1967) 2.13
Acute megakaryocytic leukemia (M7) in children. Mayo Clin Proc (1989) 2.13
Measurement of the intensity of cell surface antigen expression in B-cell chronic lymphocytic leukemia. Am J Clin Pathol (1994) 2.13
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol (1988) 2.12
Histochemical characterization of cellular and structural elements of the human spleen. J Histochem Cytochem (1972) 2.08
Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol (1987) 2.05
Dynamics of geckos running vertically. J Exp Biol (2006) 2.00
Glue-sniffing neuropathy. Arch Neurol (1975) 1.99
Cellular autofluorescence--is it due to flavins? J Histochem Cytochem (1979) 1.99
Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain (1970) 1.96
Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology (1995) 1.95
Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology (1999) 1.93
Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome. Ann Neurol (1990) 1.92
Giant axonal neuropathy--a unique case with segmental neurofilamentous masses. Acta Neuropathol (1972) 1.91
Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol (1996) 1.85
Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol (1977) 1.84
Cognitive changes 5 years after coronary artery bypass grafting: is there evidence of late decline? Arch Neurol (2001) 1.83
True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases. Blood (1995) 1.81
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81
The clinical correlates of high-titer IgG anti-GM1 antibodies. Ann Neurol (1994) 1.79
Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol (1989) 1.79
Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies. Cancer (1995) 1.77
Relapse in Guillain-Barré syndrome after treatment with human immune globulin. Neurology (1993) 1.77
Painful diabetic neuropathy. A morphometric study. Arch Neurol (1976) 1.77
Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology (2001) 1.74
Pure pan-dysautonomia with recovery. Trans Am Neurol Assoc (1969) 1.74
Encephalopathy and peripheral neuropathy following diethylene glycol ingestion. Neurology (2005) 1.73
Pseudoeosinophilia, eosinophilic endocarditis and eosinophilic leukemia. Am J Med (1972) 1.72
Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease. Genomics (1997) 1.70
Multifocal demyelinating neuropathy with persistent conduction block. Neurology (1982) 1.69
Noninvasive visualization of tumors in rodent dorsal skin window chambers. Nat Biotechnol (1999) 1.69
Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis. N Engl J Med (1971) 1.68
Dominant GDAP1 mutations cause predominantly mild CMT phenotypes. Neurology (2011) 1.67
A cohort study of cancer among benzene-exposed workers in China: overall results. Am J Ind Med (1996) 1.63
Imatinib for systemic mast-cell disease. Lancet (2003) 1.62
Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol (1988) 1.60
Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol (1996) 1.59